仅用于工业应用或科学研究,不可用于人类或动物的临床诊断或治疗,非药用. Ipilimumab (MDX-010) is a fully human monoclonal IgG1κ antibody against the cytotoxic T-lymphocyte antigen-4 (CTLA-4), an immune-inhibitory molecule expressed in activated T cells and in suppressor T regulatory cells.